Sodium zirconium cyclosilicate
- Generic Name
- Sodium zirconium cyclosilicate
- Brand Names
- Lokelma
- Drug Type
- Small Molecule
- Chemical Formula
- Na2O9Si3Zr
- CAS Number
- 17141-74-1
- Unique Ingredient Identifier
- D652ZWF066
- Background
Sodium zirconium cyclosilicate is approved as the trade product Lokelma developed by AstraZeneca - an insoluble, non-absorbed sodium zirconium silicate, formulated as a powder for oral suspension that acts as a highly selective potassium removing agent. It is administered orally and is odorless, tasteless, and stable at room temperature. Approval of the medi...
- Indication
Sodium zirconium cyclosilicate is a potassium binder indicated for the treatment of hyperkalemia in adult patients.
- Associated Conditions
- Hyperkalemia
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath